SS-A antibodies, also called anti-Ro/SS-A antibodies, are special immune system proteins that mistakenly target parts of your own cells. These antibodies usually recognize two specific proteins inside cells called Ro52 and Ro60. Both of these proteins normally help manage how cells handle RNA, a molecule important for building proteins and managing genetic information. In healthy people, the immune system ignores these proteins, but in autoimmune diseases, the body sees them as threats and attacks.
SS-A antibodies are best known for their strong association with Sjögren’s syndrome (a disease where the immune system attacks tear and saliva glands) and systemic lupus erythematosus (SLE) (a disease that can affect the skin, joints, kidneys, and other organs). They are also found in other autoimmune conditions, such as systemic sclerosis, polymyositis, dermatomyositis, mixed connective tissue disease, and primary biliary cholangitis (an autoimmune liver disease).
Ro60 mainly acts as a quality control manager for RNA inside the nucleus of cells, making sure faulty RNA gets broken down before causing trouble. Ro52, on the other hand, is a multitasker found in the cell’s cytoplasm that helps regulate the immune response by attaching a small tag called “ubiquitin” to other proteins, marking them for recycling. Interestingly, Ro52 also binds to antibodies inside cells, a backup system for clearing out infections that might sneak in.
When SS-A antibodies are present at high levels, they can have clinical consequences:
High levels of SS-A antibodies may suggest an autoimmune disease, but low levels or isolated findings can sometimes happen without clear symptoms. Some people may carry these antibodies for years before developing an illness, and a small number never develop disease at all.